Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Astrana Health organizes doctors and care for patients, especially people on government health plans, and gets paid to keep them healthy.
Astrana Health is a healthcare company that manages the messy middle of American medicine. It doesn't just own hospitals or sell drugs. Instead, it builds networks of doctors β especially primary care physicians β and then handles the business side for them: contracting with insurance plans, managing patient data, coordinating care, and taking on financial risk for how those patients do.
The core idea is simple. In the U.S., the government pays private insurers to cover people through Medicare (for seniors) and Medicaid (for low-income families). Those insurers then pay doctors. Astrana sits in between. It signs up independent doctors, gives them technology and support, and negotiates better rates with the insurers. For a growing share of its business, it goes further and accepts a fixed payment per patient β a "capitation" arrangement β meaning Astrana keeps the money if patients stay healthy and loses it if they end up in the hospital. That flips the usual incentive: instead of getting paid for doing more procedures, Astrana gets paid for keeping people out of the hospital. Its main customers are the doctors it supports and the health plans that pay for care. Patients are the people served, but they usually don't pay Astrana directly. The company makes money through management fees, shared savings when it keeps costs down, and increasingly by owning the risk itself. It grows mainly by acquiring medical groups and adding more doctors to its network β a roll-up strategy that has turned a small Los Angeles-area operation into a national player. It's headquartered in Alhambra, California, and changed its name from Apollo Medical Holdings in 2024 to signal it was more than a regional doctor group.
The business is real but not without risk. Managing care for government-insured patients is a low-margin, heavily regulated game, and Astrana's profits depend on getting its cost estimates right. If patients get sicker than expected, the fixed payments can turn into losses. Competition comes from other physician-enablement and value-based care companies, as well as from insurers themselves. But the underlying bet β that paying doctors to coordinate care beats paying them per procedure β is one of the biggest shifts in American healthcare, and Astrana is one of the companies trying to profit from it.
Saved answer Β· last researched 15 Nov 2026